
Identifai Genetics offers a novel, non-invasive prenatal testing solution that significantly improves upon existing methods. Current prenatal screening detects less than 10% of genetic disorders, and invasive tests carry risks. Identifai's technology utilizes a simple blood test from the mother during the first trimester to isolate and analyze cell-free fetal DNA. Their proprietary data science algorithms and cutting-edge bioinformatics provide early, non-invasive, and comprehensive genetic testing, capable of detecting a wider range of genetic syndromes, including point mutations and chromosomal abnormalities, with high resolution. They have conducted large-scale clinical studies with leading medical centers and have a strategic partnership with Clalit Health Services.

Identifai Genetics offers a novel, non-invasive prenatal testing solution that significantly improves upon existing methods. Current prenatal screening detects less than 10% of genetic disorders, and invasive tests carry risks. Identifai's technology utilizes a simple blood test from the mother during the first trimester to isolate and analyze cell-free fetal DNA. Their proprietary data science algorithms and cutting-edge bioinformatics provide early, non-invasive, and comprehensive genetic testing, capable of detecting a wider range of genetic syndromes, including point mutations and chromosomal abnormalities, with high resolution. They have conducted large-scale clinical studies with leading medical centers and have a strategic partnership with Clalit Health Services.